SAFETY INFORMATION

If the patients have any known allergies, should ask doctor to decide treatment with HyaRelief™ 2.0%. Only medical professionals trained in accepted injection techniques for delivering agents to intra-articular synovial joint spaces should inject sodium hyaluronate for this application.

HyaRelief™ 2.0% is recommended for patients with Osteoarthritis and Joint Diseases. The product should not be used in pregnant or breast-feeding woman, and children.

Are there any side effect of the Hyarelief?

Infection, Arthralgia (knee pain), Arthrosis,Joint (knee) disorder, Joint (knee) swelling, Joint (knee) effusion, Joint (knee) stiffness, Pain in limb, Tendonitis, Paraesthesia, Phlebitis, Pruritus, Injection site erythema, Injection site edema, Injection site pain, Injection site reaction, Arthropathy, Baker’s cyst, Bursitis, Localized osteoarthritis, Aggravated osteoarthritis, Immune Response.

What should be considered after the injection?

You avoid strenuous activities (for example, high-impact sports such as tennis or jogging) or prolonged weight-bearing activities for approximately 48 hours following the injection. 

When Should You Not Take Hyarelief?

Hyarelief should not be injected in patients with known sensitivity to any of the ingredients contained in product.
Hyarelief should not be injected in patients with pre-existing infections of the skin in the region of the intended injection site.
Hyarelief should not be administered to patients with known systemic bleeding disorders and known infection of the index joint and infected and inflamed joints.
Hyarelief may contain trace amounts of gram positive bacterial proteins so should not be administered patients with a history of such allergy.